1 – 10 of 90
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
- Cancer in older patients
- Regorafenib assessment guided by metabolic imaging in refractory advanced colorectal cancer (aCRC): REGARD-C study
- Durable disease control with sunitinib and everolimus in well-differentiated neuroendocrine tumors of the pancreas with a high ki67 index
- The 2013 update of the American Society of Clinical Oncology/College of American Pathologists guideline for HER2 testing: impact on immunohistochemistry-negative breast cancers
- A first-in-class, first-in-human phase I study of enadenotucirev, an oncolytic Ad11/Ad3 chimeric group B adenovirus, administered intravenously in patients with metastatic epithelial tumors.
- Emergence of new ALK mutations at relapse of neuroblastoma
- 2013
- Association of DNA promoter hypermethylation of decoy receptor 1 (DCR1) with poor response to irinotecan in metastatic colorectal cancer
- Outcomes of critically ill patients with hematologic malignancies: prospective multicenter data from France and Belgium: a Groupe de Recherche Respiratoire en Réanimation Onco-Hématologique study
- Safety and clinical activity of a combination therapy comprising two antibody-based targeting agents for the treatment of non-Hodgkin lymphoma: results of a phase I/II study evaluating the immunoconjugate inotuzumab ozogamicin with rituximab
- 2012
- Intrapatient cetuximab dose escalation in metastatic colorectal cancer according to the grade of early skin reactions: the randomized EVEREST study